The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.
The 30-year-old system that classifies hair texture with letters and numbers overlooks science and enforces racial biases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback